Where else but MDLinx OB/GYN can you find all the literature published in over 2,000 top peer-reviewed medical journals, ranked and summarized for you every 24 hours? Our team of physician editors is dedicated to keeping you current in less than 5 minutes a day. We cover the entirety of your diverse specialty, with subspecialty topics chosen to address the information needs of the entire women’s healthcare team, including gynecologic oncology, maternal-fetal medicine, obstetric and gynecologic surgery, ped/adolescent gynecology, repro/endo and infertility, the breast, menopausal medicine, diagnostic imaging, and much more.
Also find bonus content on this page that includes articles highlighted by our physician editor, D. Scott Cunningham, MD, PhD, that are “must-read.” Additionally, because Maintenance of Certification (MOC) is always a concern, we will provide some of the recent clinical pearls related to Obstetrics & Gynecology from our Smartest Doc and Physician Review quizzes, many of which result from a collaboration with the Cleveland Clinic Center for Continuing Education.
Your Unread Messages in Obstetrics & Gynecology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
UAE more effective than myomectomy for leiomyomas
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Oncology Clinical Pearls
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
61 WAVE1 gene silencing via RNA interference reduces ovarian cancer cell invasion, migration and proliferation Gynecologic Oncology, May 21, 2013 Clinical Article
62 Communicating risk of hereditary breast and ovarian cancer with an interactive decision support tool Patient Education and Counselling, May 21, 2013 Review Article
63 Adolescent urethral coitus: two cases and review of the literature Journal of Pediatric and Adolescent Gynecology , May 21, 2013
64 Relationship between maternal thyroid hormones and the biochemical markers of the first trimester aneuploidy screening Archives of Gynecology and Obstetrics, May 21, 2013 Clinical Article
65 Direct colposcopic vision used with the LLETZ procedure for optimal treatment of CIN: results of joint cohort studies Archives of Gynecology and Obstetrics, May 21, 2013 Clinical Article
66 Sperm exposure during menses is a risk factor for developing antisperm antibody (ASA) in female Archives of Gynecology and Obstetrics, May 21, 2013 Clinical Article
67 Platform comparisons for identification of breast cancers with a BRCA-like copy number profile Breast Cancer Research and Treatment, May 21, 2013 Review Article
68 Severe High Anion Gap Metabolic Acidosis in Pregnancy Iranian Journal of Kidney Diseases, May 21, 2013
69 Seminal plasma peptides may determine maternal immune response that alters success or failure of pregnancy in the abortion-prone CBAxDBA/2 model Journal of Reproductive Immunology, May 21, 2013 Review Article
70 Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer Full Text BMC Cancer, May 20, 2013 Clinical Article
71 Phase I dose-escalation study and population pharmacokinetic analysis of fixed dose rate gemcitabine plus carboplatin as second-line therapy in patients with ovarian cancer Gynecologic Oncology, May 20, 2013 Clinical Article
72 Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. a trial of the NCIC clinical trials group (NCIC CTG IND 199) Gynecologic Oncology, May 20, 2013 Clinical Article
73 Maternal Dietary Patterns are Associated With Risk of Neural Tube and Congenital Heart Defects American Journal of Epidemiology, May 20, 2013 Review Article
74 Value of urodynamics before stress urinary incontinence surgery: a randomized controlled trial Obstetrics and gynecology, May 20, 2013 Clinical Article
75 Measures of cardiovascular risk and subclinical atherosclerosis in a cohort of women with a remote history of preeclampsia Atherosclerosis, May 20, 2013 Clinical Article
76 Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time Breast Cancer Research, May 20, 2013 Clinical Article
77 Loss of dok2 induces carboplatin resistance in ovarian cancer via suppression of apoptosis Gynecologic Oncology, May 20, 2013 Clinical Article
78 Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907 Breast Cancer Research and Treatment, May 20, 2013 Clinical Article
79 Detection of disseminated tumor cells in locally advanced breast cancer patients before primary systemic therapy The Breast, May 20, 2013 Clinical Article
80 Patients Anastrozole Compliance to Therapy (PACT) Program: Baseline Data and Patient Characteristics from a Population-Based, Randomized Study Evaluating Compliance to Aromatase Inhibitor Therapy in Postmenopausal Women with Hormone-Sensitive Early Breast Cancer Breast Care, May 20, 2013 Clinical Article
Based on a review article published in BMC Infectious Diseases, it has been concluded that antiseptics have equal efficacy to antibiotics in the treatment of bacterial vaginosis. The literature search covered the time period 1966-2010. Benzydamine, chlorhexidine, and polyhexamethylene niguanide were as effective as metronidazole and clindamycin in the short-term treatment of bacterial vaginosis.
Read the article summaryBased on an observational study orchestrated by researchers at the M D Anderson Cancer Center, BRCA2 mutations have been associated with improved survival in patients with high-grade serous ovarian cancer. The 5-year OS in patients with BRCA2 mutations was 61% compared with 25% for patients with BRCA wild-type. The 3-year PFS in patients with BRCA2 mutations was 44% compared with 16% for patients with BRCA wild-type. Patients with BRCA2 mutations exhibited 100% chemosensitivity compared to 82% and 80% for patients with BRCA wild-type and BRCA1 mutations, respectively. Genomic analysis of the tumors from patients with BRCA2 mutations suggested a “mutator phenotype” compared to tumors from patients with BRCA1 mutations.
Read the article summaryIn a study involving 87,025 postmenopausal women, those in the highest quintile of dietary trans fat had an increased risk of ischemic stroke (HR=1.39). In 663,041 person-years of follow-up, 1049 incident cases of ischemic stroke were reported. The effect was attenuated in aspirin users (HR=0.95) compared to non-users (HR=1.66).
Read the article summaryIndexed Journals in Obstetrics & Gynecology: Obstetrics and Gynecology, American Journal of Obstetrics and Gynecology more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close